Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Gemcitabine

5

X.c Capillary leak syndrome (CLS)

1
Last update : 15/04/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Separate episodes of capillary leak syndrome and pulmonary hypertension after adjuvant gemcitabine and three years later after nab-paclitaxel for metastatic disease.
BMC cancer 2013 Nov 12;13;542 2013 Nov 12
Cure of gemcitabine-induced systemic capillary leak syndrome without corticosteroids.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology 2009;14;728-9 2009
Gemcitabine: vascular toxicity and prothrombotic potential.
Expert opinion on drug safety 2008 Nov;7;703-16 2008 Nov
Gemcitabine-induced chronic systemic capillary leak syndrome: a life-threatening disease.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2006 Feb;18;90-1 2006 Feb
Severe gemcitabine-induced capillary-leak syndrome mimicking cardiac failure in a patient with advanced pancreatic cancer and high-risk cardiovascular disease.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2004 Dec;16;577-9 2004 Dec
Gemcitabine-induced systemic capillary leak syndrome.
Annals of oncology : official journal of the European Society for Medical Oncology 2001 Nov;12;1651-2 2001 Nov

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies